Barclays PLC lowered its stake in Integer Holdings Corp (NYSE:ITGR) by 2.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 41,396 shares of the medical equipment provider’s stock after selling 1,188 shares during the period. Barclays PLC owned approximately 0.13% of Integer worth $3,128,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently modified their holdings of the company. DekaBank Deutsche Girozentrale bought a new position in Integer in the second quarter valued at about $66,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Integer by 29.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,178 shares of the medical equipment provider’s stock valued at $165,000 after purchasing an additional 495 shares in the last quarter. Sciencast Management LP acquired a new stake in shares of Integer during the third quarter valued at about $204,000. Palouse Capital Management Inc. acquired a new stake in shares of Integer during the second quarter valued at about $243,000. Finally, Campbell & CO Investment Adviser LLC acquired a new stake in shares of Integer during the third quarter valued at about $287,000. Institutional investors own 98.11% of the company’s stock.
Shares of ITGR stock opened at $75.01 on Tuesday. The business’s 50-day moving average price is $75.31 and its 200-day moving average price is $77.03. Integer Holdings Corp has a 12 month low of $67.72 and a 12 month high of $92.61. The firm has a market capitalization of $2.48 billion, a price-to-earnings ratio of 19.74 and a beta of 1.01. The company has a current ratio of 2.40, a quick ratio of 1.35 and a debt-to-equity ratio of 0.73.
Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, October 31st. The medical equipment provider reported $1.20 EPS for the quarter, topping the Zacks’ consensus estimate of $1.06 by $0.14. The company had revenue of $303.59 million for the quarter, compared to analyst estimates of $313.78 million. Integer had a return on equity of 13.47% and a net margin of 8.99%. The firm’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.06 earnings per share. On average, sell-side analysts predict that Integer Holdings Corp will post 4.6 earnings per share for the current fiscal year.
Separately, ValuEngine raised Integer from a “sell” rating to a “hold” rating in a research note on Tuesday. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $65.76.
In related news, Director Pamela G. Bailey sold 7,446 shares of Integer stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $76.75, for a total value of $571,480.50. Following the transaction, the director now directly owns 56,990 shares of the company’s stock, valued at $4,373,982.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.24% of the stock is owned by insiders.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Featured Article: Options Trading
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corp (NYSE:ITGR).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.